Zealand Pharma A/s diskutieren
Zealand Pharma A/s
WKN: A0YJW7 / Name: Zealand / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
Zealand Pharma vor den Zahlen steht vor einem starken Jahr 2015.
Kaufsignal.
tamam stimmt dem Sentiment von 'Buy' zu
tamam stimmt am 11.01.2018 dem Buy-Gesamtsentiment mit dem Kursziel 21.0€ zu.
I chose ZEAL due to credibility from partnerships, royalties and milestones from approved partnered drugs and associated credibility, with high upside due to large markets being targeted with wholly owned treatments.
stratec stimmt der Outperform-Einschätzung der institutionellen Analysten zu
stratec stimmt am 12.06.2018 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 21.41€ zu.
ZEAL announced updated top-line findings from its ongoing phase 3 study evaluating dasiglucagon compared with glucagon. The study met its primary and key secondary endpoints, which included immunogenicity and safety/tolerability of this glucagon mimetic. This builds on phase 2 findings showing long-lasting recovery of plasma glucose, suggesting efficacy for this agent.
Neueste Beiträge
Akuma in Biontech SE diskutieren, BioNTech SE ADR